According to the authors, vaccine effectiveness against infection reached 44.7% (95% confidence interval [CI], 37.7% to 50.9%) 4 weeks postvaccination, declined to 35.5% (95% CI, 30.2% to 40.5%) at 10 ...

Updated COVID-19 vaccines are still providing effective protection against infection, emergency department visits, ...

Updated COVID-19 vaccines are still providing effective protection against infection, emergency department visits, ...

The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical ...

Moderna's mRNA-1273 vaccine helped prevent medically attended COVID-19 and related hospitalizations across multiple respiratory seasons among adults.

Getting a COVID shot might do more than protect against the virus – it could also help cancer patients live longer. A new ...

The 2025-2026 COVID-19 vaccines available in the United States include Moderna, Pfizer-BioNTech and Novavax. The vaccines are all approved for people age 65 and older. Each vaccine also is approved ...

A study revealed that the 2024-2025 COVID-19 vaccine significantly reduces emergency visits, hospitalizations and deaths among U.S. veterans.

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about a new study that shows the Shingles vaccine being ...

Texas AG Ken Paxton warned Houston Methodist Hospital over alleged COVID-19 vaccine mandates for organ transplant patients, ...

Hospitalization for rotavirus infections decreased by > 70% following the introduction of a vaccine program in Ontario, Canada, according to a study published May 11, 2016 in the open-access journal ...